Controlling the complement system in inflammation
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Immunopharmacology
- Vol. 38 (1-2) , 51-62
- https://doi.org/10.1016/s0162-3109(97)00057-x
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Mannose-binding lectin: the pluripotent molecule of the innate immune systemImmunology Today, 1996
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Journal of Clinical Investigation, 1995
- Effect of substituted dextran derivative on complement activation in vivoBiomaterials, 1995
- Protective effect of cobra venom factor on pulmonary injury induced by oleic acidInternational Journal of Immunopharmacology, 1994
- Leukocyte Adhesion Deficiency Syndrome: Insights into the Molecular Basis of Leukocyte EmigrationClinical Immunology and Immunopathology, 1993
- C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2Intensive Care Medicine, 1993
- INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTORTransplantation, 1991
- Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndromeClinical and Experimental Immunology, 1990
- Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextransBiomaterials, 1987
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986